Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 1 | 204546897 | intron variant | A/G | snv | 0.65 | 0.57 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.810 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.708 | 0.360 | 1 | 204549714 | 3 prime UTR variant | C/A;G | snv | 0.77; 6.2E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.730 | 0.800 | 5 | 2013 | 2018 | |||||||
|
0.708 | 0.360 | 1 | 204549714 | 3 prime UTR variant | C/A;G | snv | 0.77; 6.2E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.730 | 0.750 | 4 | 2013 | 2018 | |||||||
|
0.708 | 0.360 | 1 | 204549714 | 3 prime UTR variant | C/A;G | snv | 0.77; 6.2E-06 |
|
Neoplasms; Male Urogenital Diseases | 0.720 | 1.000 | 4 | 2013 | 2018 | |||||||
|
0.708 | 0.360 | 1 | 204549714 | 3 prime UTR variant | C/A;G | snv | 0.77; 6.2E-06 |
|
Neoplasms; Male Urogenital Diseases | 0.720 | 1.000 | 3 | 2013 | 2015 | |||||||
|
0.708 | 0.360 | 1 | 204549714 | 3 prime UTR variant | C/A;G | snv | 0.77; 6.2E-06 |
|
0.700 | 1.000 | 2 | 2016 | 2018 | ||||||||
|
1 | 204557932 | 3 prime UTR variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
0.708 | 0.360 | 1 | 204549714 | 3 prime UTR variant | C/A;G | snv | 0.77; 6.2E-06 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 1 | 204539019 | intron variant | G/A | snv | 0.17 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 1 | 204539019 | intron variant | G/A | snv | 0.17 |
|
Neoplasms; Nervous System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.708 | 0.360 | 1 | 204549714 | 3 prime UTR variant | C/A;G | snv | 0.77; 6.2E-06 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2013 | 2016 | |||||||
|
0.708 | 0.360 | 1 | 204549714 | 3 prime UTR variant | C/A;G | snv | 0.77; 6.2E-06 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2013 | 2016 | |||||||
|
0.763 | 0.240 | 1 | 204519150 | intron variant | G/C | snv | 0.57 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||||
|
0.763 | 0.240 | 1 | 204519150 | intron variant | G/C | snv | 0.57 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||||
|
0.882 | 0.120 | 1 | 204556440 | 3 prime UTR variant | G/C;T | snv | 0.38 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 1 | 204556440 | 3 prime UTR variant | G/C;T | snv | 0.38 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 1 | 204556440 | 3 prime UTR variant | G/C;T | snv | 0.38 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.120 | 1 | 204556440 | 3 prime UTR variant | G/C;T | snv | 0.38 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.080 | 1 | 204538255 | missense variant | A/G | snv | 4.4E-04 | 4.7E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.925 | 0.080 | 1 | 204538255 | missense variant | A/G | snv | 4.4E-04 | 4.7E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.763 | 0.240 | 1 | 204519150 | intron variant | G/C | snv | 0.57 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.240 | 1 | 204519150 | intron variant | G/C | snv | 0.57 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.240 | 1 | 204519150 | intron variant | G/C | snv | 0.57 |
|
Neoplasms; Eye Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.240 | 1 | 204519150 | intron variant | G/C | snv | 0.57 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.763 | 0.240 | 1 | 204519150 | intron variant | G/C | snv | 0.57 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |